xperiment.ca content references: heroin · xperiment.ca content references: heroin ... h.b., &...

Xperiment.ca Content References: Heroin

© Canadian Centre on Substance Abuse | February 2011 of 15

Heroin References

Adeniji, A.A., Purcell, A., Pearson, L., Antcliffe, J.M., Tutty, S., Sinha, C., et al. (2010).

Multidisciplinary antenatal care for opiate-using women: Child-care issues. Drug and

Alcohol Review, 29(2), 189–192.

Ahmad, S., Ahmad, H., & Bindra, G. (1989). Cognitive impairment in chronic heroin

addicts. Journal of Personality and Clinical Studies, 5, 237–240.

Alipour, F., Hashemi, H., Piri, N., & Asghari, H. (2010). Ocular manifestations of

transconjunctival heroin abuse: A case report of an unusual route of substance abuse.

Cornea, 29(1), 110–112.

Amir, T., & Bahri, T. (1994). Effect of substance-abuse on visuographic function. Perceptual

and Motor Skills, 78, 235–241.

Awgu, E., Magura, S., & Rosenblum, A. (2010). Heroin-dependent inmates' experiences with

buprenorphine or methadone maintenance. Journal of Psychoactive Drugs, 42(3),

339–346.

Barghi, R.G., & Mirakbari, S.M. (2010). Septic arthritis of sternoclavicular joint: A case

report of a rare finding in injecting drug users. Archives of Iranian Medicine, 13(3),

248–250.

Blanken, P., Hendriks, V.M., van Ree, J.M., & van den Brink, W. (2010). Outcome of long-

term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in

the Netherlands. Addiction (Abingdon, England), 105(2), 300–308.

Blasel, S., Hattingen, E., Adelmann, M., Nichtweiss, M., Zanella, F., & Weidauer, S. (2010).

Toxic leukoencephalopathy after heroin abuse without heroin vapor inhalation: MR

imaging and clinical features in three patients. [Toxische leukoenzephalopathie nach

nichtinhalativem heroinabusus. MR-bildgebung und klinischer verlauf bei drei

patienten.] Clinical Neuroradiology, 20(1), 48–53.

Brener, L., von Hippel, W., von Hippel, C., Resnick, I., & Treloar, C. (2010). Perceptions of

discriminatory treatment by staff as predictors of drug treatment completion: Utility

of a mixed methods approach. Drug and Alcohol Review, 29(5), 491–497.

Bruhn, P., & Maage, N. (1975). Intellectual and neuropsychological functions in young men

with heavy and long-term patterns of drug abuse. American Journal of Psychiatry,

132, 397– 401.

Cavanaugh, C.E., Hedden, S.L., & Latimer, W.W. (2010). Sexually transmitted infections

among pregnant heroin- or cocaine-addicted women in treatment: The significance of

psychiatric co-morbidity and sex trade. International Journal of STD & AIDS, 21(2),

141–142.



Chen, V.C., Lin, T.Y., Lee, C.T., Lai, T.J., Chen, H., Ferri, C.P., et al. (2010). Suicide

attempts prior to starting methadone maintenance treatment in Taiwan. Drug and

Alcohol Dependence, 109(1–3), 139–143.

Chien, C.C., Lin, C.H., Chang, Y.Y., & Lung, F.W. (2010). Association of VNTR

polymorphisms in the MAOA promoter and DRD4 exon 3 with heroin dependence in

male Chinese addicts. World Journal of Biological Psychiatry, 11(2 Pt 2), 409–416.

Clatts, M., Giang le, M., Goldsamt, L., & Colon-Lopez, V. (2010). Nonmedical use of

promethazine hydrochloride among heroin injectors in Vietnam: Unrecognized risks

and unintended consequences. Substance Use and Misuse, 45(4), 515–527.

Clatts, M.C., Colon-Lopez, V., Giang le, M., & Goldsamt, L.A. (2010). Prevalence and

incidence of HCV infection among Vietnam heroin users with recent onset of

injection. Journal of Urban Health: Bulletin of the New York Academy of Medicine,

87(2), 278–291.

Comer, S.D., Sullivan, M.A., Vosburg, S.K., Manubay, J., Amass, L., Cooper, Z.D., et al.

(2010). Abuse liability of intravenous buprenorphine/naloxone and buprenorphine

alone in buprenorphine-maintained intravenous heroin abusers. Addiction (Abingdon,

England), 105(4), 709–718.

Comiskey, C.M., & Cox, G. (2010). Analysis of the impact of treatment setting on outcomes

from methadone treatment. Journal of Substance Abuse Treatment, 39(3), 195–201.

Darke, S., Duflou, J., & Torok, M. (2010). The comparative toxicology and major organ

pathology of fatal methadone and heroin toxicity cases. Drug and Alcohol

Dependence, 106(1), 1–6.

Darke, S., Duflou, J., & Torok, M. (2010). Comparative toxicology of intentional and

accidental heroin overdose. Journal of Forensic Sciences, 55, 1015–1018.

Darke, S., Duflou, J., & Torok, M. (2010). A reduction in blood morphine concentrations

amongst heroin overdose fatalities associated with a sustained reduction in street

heroin purity. Forensic Science International, 198(1–3), 118–120.

Darke, S., Ross, J., Mills, K., Teesson, M., Williamson, A., & Havard, A. (2010).

Benzodiazepine use among heroin users: Baseline use, current use and clinical

outcome. Drug and Alcohol Review, 29(3), 250–255.

Darke, S., Torok, M., Kaye, S., Ross, J., & McKetin, R. (2010). Comparative rates of violent

crime among regular methamphetamine and opioid users: Offending and

victimization. Addiction (Abingdon, England), 105(5), 916–919.

Darke, S., Hall, W., Weatherburn, D., & Lind, B. (1999). Fluctuations in heroin purity and

the incidence of fatal heroin overdose. Drug and Alcohol Dependence, 54, 155–161.



Darke, S., & Zador, D. (1996). Fatal heroin ‘overdose’: A review. Addiction, 91, 1765–1772.

Demetrovics, Z., Varga, G., Szekely, A., Vereczkei, A., Csorba, J., Balazs, H., et al. (2010).

Association between novelty seeking of opiate-dependent patients and the catechol-

O-methyltransferase val(158)met polymorphism. Comprehensive Psychiatry, 51(5),

510–515.

De Vries, T.J., & Shippenberg, T.S. (2002). Neural systems underlying opiate addiction.

Journal of Neuroscience, 22, 3321–3325.

Dickson, A.J., Vorce, S.P., Levine, B., & Past, M.R. (2010). Multiple-drug toxicity caused by

the coadministration of 4-methylmethcathinone (mephedrone) and heroin. Journal of

Analytical Toxicology, 34(3), 162–168.

dos Santos, M.M., Rataemane, S.T., Fourie, D., & Trathen, B. (2010). An approach to heroin

use disorder intervention within the South African context: A content analysis study.

Substance Abuse Treatment, Prevention, and Policy, 5, 13.

Dursteler-MacFarland, K.M., Fischer, D.A., Mueller, S., Schmid, O., Moldovanyi, A., &

Wiesbeck, G.A. (2010). Symptom complaints of patients prescribed either oral

methadone or injectable heroin. Journal of Substance Abuse Treatment, 38(4), 328–

337.

Eiroa-Orosa, F.J., Verthein, U., Kuhn, S., Lindemann, C., Karow, A., Haasen, C., et al.

(2010). Implication of gender differences in heroin-assisted treatment: Results from

the German randomized controlled trial. American Journal on Addictions, 19(4),

312–318.

Elia, D., Marinou, A., & Chetta, A. (2010). Life-threatening asthma after heroin inhalation: A

case report and a review of the literature. Acta Bio Medica: Atenei Parmensis, 81(1),

63–67.

Enoch, M.A., Hodgkinson, C.A., Yuan, Q., Shen, P.H., Goldman, D., & Roy, A. (2010). The

influence of GABRA2, childhood trauma, and their interaction on alcohol, heroin,

and cocaine dependence. Biological Psychiatry, 67(1), 20–27.

Epstein, D.H., Marrone, G.F., Heishman, S.J., Schmittner, J., & Preston, K.L. (2010).

Tobacco, cocaine, and heroin: Craving and use during daily life. Addictive Behaviors,

35(4), 318–324.

Ersche, K.D., Clark, L., London, M., Robbins, T.W., & Sahakian, B.J. (2006). Profile of

executive and memory function associated with amphetamine and opiate dependence.

Neuropsychopharmacology, 31, 1036–1047.

Ersche, K.D., & Sahakian, B.J. (2007). The neuropsychology of amphetamine and opiate

dependence: Implications for treatment. Neuropsychology Review, 17, 317–336.



Eslami Shahrbabaki, M., Ziaaddini, H., Saieedi, H., & Nakhaiee, N. (2010). Disruptive

behavior disorders in 8 to 14 years old offspring of opium and heroin dependent

parents: A case-control study. Journal of Addiction and Health, 1(2).

Everitt, B.J., & Robbins, T.W. (2005). Neural systems of reinforcement for drug addiction:

from actions to habits to compulsion. Nature Neuroscience, 8, 1481–1489.

Fatovich, D.M., Bartu, A., Davis, G., Atrie, J., & Daly, F.F. (2010). Morbidity associated

with heroin overdose presentations to an emergency department: A 10-year record

linkage study. Emergency Medicine Australasia, 22(3), 240–245.

Fernandez-Serrano, M.J., Perez-Garcia, M., Perales, J.C., & Verdejo-Garcia, A. (2010).

Prevalence of executive dysfunction in cocaine, heroin and alcohol users enrolled in

therapeutic communities. European Journal of Pharmacology, 626(1), 104–112.

Ferri, M., Davoli, M., & Perucci, C.A. (2010). Heroin maintenance for chronic heroin-

dependent individuals. Cochrane Database of Systematic Reviews (Online), 8(8),

CD003410.

Fishbein, D., Krupitsky, E., Flannery, B., Langevin, D.J., Bobashev, G., Verbitskaya, E.,

Augustine, C., Bolla, K., Zvartau, E., Schech, B., Egorova, V., Bushara, N., & Tsoy,

M. (2007). Neurocognitive characterizations of Russian heroin addicts without a

significant history of other drug use. Drug and Alcohol Dependence, 90, 25–38.

Frick, U., Wiedermann, W., Schaub, M., Uchtenhagen, A., & Rehm, J. (2010). Prognostic

factors from a long-term follow-up of heroin-assisted treatment in Switzerland 1994-

2007]. [Heroingestutzte behandlung in der Schweiz im langzeitverlauf 1994-2007:

Einflussfaktoren auf den behandlungserfolg.] Psychiatrische Praxis, 37(4), 175–182.

Gabilondo, A.M., Meana, J.J., Barturen, F., Sastre, M., & Garcia-Sevilla, J. A. (1994). μ-

Opioid receptor and 2-adrenoceptor agonist binding sites in the postmortem brain of

heroin addicts. Psychopharmacology, 115, 135–140.

Ghaffari, A., Ziaadini, H., & Banazadeh, N. (2010). Comparative evaluation of psychiatric

disorders in opium and heroin dependent patients. Journal of Addiction and Health,

1(1).

Gilman, A.G., Goodman, L.S., Rall, T.W., & Murad, F. (Eds.). (1990). The pharmacological

basis of therapeutics (8th ed.). New Jersey: Pergamon Press.

Greenwald, M.K. (2010). Effects of experimental unemployment, employment and

punishment analogs on opioid seeking and consumption in heroin-dependent

volunteers. Drug and Alcohol Dependence, 111(1–2), 64–73.



Grigorakos, L., Sakagianni, K., Tsigou, E., Apostolakos, G., Nikolopoulos, G., & Veldekis,

D. (2010). Outcome of acute heroin overdose requiring intensive care unit admission.

Journal of Opioid Management, 6(3), 227–231.

Gruber, S.A., Silveri, M.M., Renshaw, P.F., Tzilos, G.K., Pollack, M., Kaufman, M.J., et al.

(2006). Methadone maintenance improves cognitive performance after two months of

treatment. Experimental and Clinical Psychopharmacology, 14, 157–164.

Gruber, S.A., Silveri, M.M., & Yurgelun-Todd, D.A. (2007). Neuropsychological

consequences of opiate use. Neuropsychology Review, 17, 299–315.

Guerra, D., Sole, A., Cami, J., & Tobena A. (1987). Neuropsychological performance in

opiate addicts after rapid detoxification. Drug and Alcohol Dependence, 20, 261–270.

Gutstein, H.B., & Akil, H. (2005). In L. Brunton, J. Lazo, & K. Parker (Eds.). The

pharmacological basis of theraputics, vol. 1. (pp. 547–590). New York: MacMillan

Publishing Company.

Haasen, C., Verthein, U., Eiroa-Orosa, F.J., Schafer, I., & Reimer, J. (2010). Is heroin-

assisted treatment effective for patients with no previous maintenance treatment?

results from a German randomised controlled trial. European Addiction Research,

16(3), 124–130.

Han, B., Gfroerer, J.C., & Colliver, J.D. (2010). Associations between duration of illicit drug

use and health conditions: Results from the 2005-2007 national surveys on drug use

and health. Annals of Epidemiology, 20(4), 289–297.

Hart, N., Rocha, A., Miller, D.K., & Nation, J.R. (2010). Dose-dependent attenuation of

heroin self-administration with lobeline. Journal of Psychopharmacology (Oxford,

England), 24(1), 51–55.

Hiramatsu, M. (2010). Opium (heroin * morphine). Japanese Journal of Clinical Medicine,

68(8), 1506–1510.

Hulse, G.K., Ngo, H.T., & Tait, R.J. (2010). Risk factors for craving and relapse in heroin

users treated with oral or implant naltrexone. Biological Psychiatry, 68(3), 296–302.

Hyde, S.T. (2010). Global flows in drug treatment: Heroin addiction and therapeutic

community approaches in China. Asia-Pacific Journal of Public Health, 22(3 Suppl),

197S–202S.

Ilic, G., Gligorijevic, J., Milosavljevic, I., & Karadzic, R. (2010). Evaluation of

morphological changes of the liver caused by heroin abuse in forensic practice.

Military-Medical and Pharmaceutical Review, 67(5), 403–410.



Ilic, G., Karadzic, R., Kostic-Banovic, L., Stojanovic, J., & Antovic, A. (2010).

Ultrastructural changes in the liver of intravenous heroin addicts. Bosnian Journal of

Basic Medical Sciences, 10(1), 38–43.

Iliceto, P., Pompili, M., Girardi, P., Lester, D., Vincenti, C., Rihmer, Z., et al. (2010).

Hopelessness, temperament, and health perception in heroin addicts. Journal of

Addictive Diseases, 29(3), 352–358.

Jaffe, J.H., & Martin, W.R. (1990). Opioid analgesics and antagonists. In A.G. Gilman, T.W.

Rall, A.S. Nies, & P. Taylor (Eds.). The pharmacological basis of therapeutics (8th

ed.) (pp. 485–521). New York: Pergamon Press.

Jian-qiang, R., & Ping, X. (2010). Advancement in heroin dependence and related gene.

Medical Recapitulate.

Kalant, H., LeBlanc, A.E., & Gibbins, R.J. (1971). Tolerance to, and dependence on some

non-opiate psychotropic drugs. Pharmacological Reviews, 23, 135–191.

Kazma, M., Izrael, M., Revel, M., Chebath, J., & Yanai, J. (2010). Survival, differentiation,

and reversal of heroin neurobehavioral teratogenicity in mice by transplanted neural

stem cells derived from embryonic stem cells. Journal of Neuroscience Research,

88(2), 315–323.

Kish, S.J. , Kalasinsky, K.S., Derkach, P., Schmunk, G.A., Guttman, M., Ang, L., Adams, V.,

Furukawa, Y., & Haycock, J.W. (2001). Striatal dopaminergic and serotonergic

markers in human heroin users. Neuropsychopharmacology, 24, 561–567.

Kopetz, C.E., Reynolds, E.K., Hart, C.L., Kruglanski, A.W., & Lejuez, C.W. (2010). Social

context and perceived effects of drugs on sexual behavior among individuals who use

both heroin and cocaine. Experimental and Clinical Psychopharmacology, 18(3),

214–220.

Kouros, D., Tahereh, H., Mohammadreza, A., & Minoo, M.Z. (2010). Opium and heroin

alter biochemical parameters of human's serum. American Journal of Drug and

Alcohol Abuse, 36(3), 135–139.

Kovatsi, L., Njau, S., Nikolaou, K., Topouridou, K., Papamitsou, T., & Koliakos, G. (2010).

Evaluation of prooxidant-antioxidant balance in chronic heroin users in a single

assay: An identification criterion for antioxidant supplementation. American Journal

of Drug and Alcohol Abuse, 36(4), 228–232.

Kovatsi, L., Njau, S., Nikolaou, K., Tsolakidou, A., Karamouzis, I., & Thisiadou, K. (2010).

Isoprostane as a marker of oxidative stress in chronic heroin users: Correlation with

duration of heroin use or concomitant hepatitis C infection. American Journal of

Drug and Alcohol Abuse, 36(1), 13–17.



Krakauer, E.L., Wenk, R., Buitrago, R., Jenkins, P., & Scholten, W. (2010). Opioid

inaccessibility and its human consequences: Reports from the field. Journal of Pain

and Palliative Care Pharmacotherapy, 24(3), 239–243.

Kreek, M.J., Borg, L., Ducat, E., & Ray, B. (2010). Pharmacotherapy in the treatment of

addiction: Methadone. Journal of Addictive Diseases, 29(2), 200–216.

Lasnier, B., Brochu, S., Boyd, N., & Fischer, B. (2010). A heroin prescription trial: Case

studies from Montreal and Vancouver on crime and disorder in the surrounding

neighbourhoods. International Journal of Drug Policy, 21(1), 28–35.

Lee, T.M., & Pau, C.W. (2002). Impulse control differences between abstinent heroin users

and matched controls. Brain Injury, 16, 885–889.

Lee, T.M.C., Zhou, W.H., Luo, X.J., Yuen, K.S.L., Ruan, X.Z., & Weng, X.C. (2005).

Neural activity associated with cognitive regulation in heroin users: A fMRI study.

Neuroscience Letters, 382, 211–216.

Li, L., Sangthong, R., Chongsuvivatwong, V., Mcneil, E., & Li, J.H. (2010). Lifetime

multiple substance use pattern among heroin users before entering methadone

maintenance treatment clinic in Yunnan, China. Drug and Alcohol Review, 29(4),

420–425.

Litchfield, J., Maronge, A., Rigg, T., Rees, B., Harshey, R., & Keen, J. (2010). Can a

targeted GP-led clinic improve outcomes for street sex workers who use heroin?

British Journal of General Practice, 60(576), 514–516.

Lorenzetti, V., Lubman, D.I., Velakoulis, D., & Yucel, M. (2010). Pituitary gland volume

among heroin users stabilised on substitution pharmacotherapy. Drug and Alcohol

Dependence, 110(1–2), 164–166.

Lu, B., Li, M., Hou, Y.Y., Chen, J., Chi, Z.Q., & Liu, J.G. (2010). Initial experience of

heroin use under a two-chained operant schedule influences drug-seeking behavior

after one month of abstinence. Acta Pharmacologica Sinica, 31(4), 387–392.

Maisto, S.A., Galizio, M., & Connors, G.J. (2008). Drug use and abuse (5th ed.). Belmont,

CA: Wadsworth.

Maldonado, R. (1997). Participation of noradrenergic pathways in the expression of opiate

withdrawal: Biochemical and pharmacological evidence. Neuroscience and

Biobehavioral Reviews, 21, 91–104.

Manning, F.J., & Ingraham, L.H. (1983). Drug ‘overdoses’ among U.S. soldiers in Europe,

1978-1979: Demographics and toxicology. International Journal of the Addictions,

18(2), 153–166.



Maremmani, I., Stefania, C., Pacini, M., Maremmani, A.G., Carlini, M., Golia, F., et al.

(2010). Differential substance abuse patterns distribute according to gender in heroin

addicts. Journal of Psychoactive Drugs, 42(1), 89–95.

Martin, M., Vanichseni, S., Suntharasamai, P., Mock, P.A., van Griensven, F., Pitisuttithum,

P., et al. (2010). Drug use and the risk of HIV infection amongst injection drug users

participating in an HIV vaccine trial in Bangkok, 1999-2003. International Journal of

Drug Policy, 21(4), 296–301.

Martinova, H., Donchev, T., Milanova, V., & Akiskal, H. (2010). Does heroin addiction

makes temperamental changes? Annals of General Psychiatry, 9(Suppl 1), S141.

Mateu-Gelabert, P., Sandoval, M., Meylakhs, P., Wendel, T., & Friedman, S.R. (2010).

Strategies to avoid opiate withdrawal: Implications for HCV and HIV risks.

International Journal on Drug Policy, 21(3), 179–185.

Megarbane, B., Buisine, A., Jacobs, F., Resiere, D., Chevillard, L., Vicaut, E., et al. (2010).

Prospective comparative assessment of buprenorphine overdose with heroin and

methadone: Clinical characteristics and response to antidotal treatment. Journal of

Substance Abuse Treatment, 38(4), 403–407.

Mei, W., Zhang, J.X., & Xiao, Z. (2010). Acute effects of sublingual buprenorphine on brain

responses to heroin-related cues in early-abstinent heroin addicts: An uncontrolled

trial. Neuroscience, 170(3), 808–815.

Messinis, L., Andrian, V., Lyros, E., Papathanasiou, T., Panagis, G., & Papathanasopoulos,

P. (2010). P03-234-cognitive functions in buprenorphine maintained patients versus

abstinent heroin abusers on naltrexone hydrochloride therapy. European Psychiatry,

25(S1), 1301.

Mintzer, M.Z., Copersino, M.L., & Stitzer, M.L. (2005). Opioid abuse and cognitive

performance. Drug and Alcohol Dependence, 78, 225–230.

National Institute on Drug Abuse. (2005). Heroin abuse and addiction (NIDA Research

Report Series).

Nielsen, D.A., Hamon, S., Yuferov, V., Jackson, C., Ho, A., Ott, J., et al. (2010). Ethnic

diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of

heroin addicts. Human Genetics, 127(6), 639–649.

Nielsen, D.A., Ji, F., Yuferov, V., Ho, A., He, C., Ott, J., et al. (2010). Genome-wide

association study identifies genes that may contribute to risk for developing heroin

addiction. Psychiatric Genetics, 20, 207–214.

Nordt, C., & Stohler, R. (2010). Combined effects of law enforcement and substitution

treatment on heroin mortality. Drug and Alcohol Review, 29(5), 540–545.



Nosyk, B., Geller, J., Guh, D.P., Oviedo-Joekes, E., Brissette, S., Marsh, D.C., et al. (2010).

The effect of motivational status on treatment outcome in the North American Opiate

Medication Initiative (NAOMI) study. Drug and Alcohol Dependence, 111(1–2),

161–165.

Nutt, D.J. (2010). Antagonist-agonist combinations as therapies for heroin addiction: Back to

the future? Journal of Psychopharmacology (Oxford, England), 24(2), 141–145.

Oliver, P., Keen, J., Rowse, G., Ewins, E., Griffiths, L., & Mathers, N. (2010). The effect of

time spent in treatment and dropout status on rates of convictions, cautions and

imprisonment over 5 years in a primary care-led methadone maintenance service.

Addiction (Abingdon, England), 105(4), 732–739.

Oppenheimer, E., Tobbutt, G., Taylor, C., & Andrew, T. (1994). Death and survival in a

cohort of heroin addicts from London clinics: A 22-year follow-up study. Addiction,

89, 1299–1308.

Ornstein, T.J., Iddon, J.L., Baldacchino, A.M., Sahakian, B.J., London, M., Everitt, B.J., &

Robbins, T.W. (2000). Profiles of cognitive dysfunction in chronic amphetamine and

heroin abusers. Neuropsychopharmacology, 23, 113–26.

Oviedo-Joekes, E., Guh, D., Brissette, S., Marsh, D.C., Nosyk, B., Krausz, M., et al. (2010).

Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of

opioid dependence: A pilot study. Journal of Substance Abuse Treatment, 38(4), 408–

411.

Oviedo-Joekes, E., Guh, D., Brissette, S., Marchand, K., Marsh, D., Chettiar, J., et al. (2010).

Effectiveness of diacetylmorphine versus methadone for the treatment of opioid

dependence in women. Drug and Alcohol Dependence, 111(1–2), 50–57.

Oviedo-Joekes, E., Guh, D., Marsh, D.C., Brissette, S., Nosyk, B., Krausz, M., et al. (2010).

Characteristics and response to treatment among aboriginal people receiving heroin-

assisted treatment. Canadian Journal of Public Health, 101(3), 210–212.

Oviedo-Joekes, E., March, J.C., Romero, M., & Perea-Milla, E. (2010). The Andalusian trial

on heroin-assisted treatment: A 2 year follow-up. Drug and Alcohol Review, 29(1),

75–80.

Pakesch, G., Loimer, N., Grunberger, J., Pfersmann, D., Linzmayer, L., & Mayerhofer, S.

(1992). Neuropsychological findings and psychiatric symptoms in HIV-1 infected and

noninfected drug users. Psychiatry Research, 41, 163–177.

Palepu, A., Marshall, B.D.L., Lai, C., Wood, E., & Kerr, T. (2010). Addiction treatment and

stable housing among a cohort of injection drug users. PLoS One, 5(7), e11697.



Phillips, K.T., & Stein, M.D. (2010). Risk practices associated with bacterial infections

among injection drug users in Denver, Colorado. American Journal of Drug and

Alcohol Abuse, 36(2), 92–97.

Pong, K.M., Abdel-Latif, M.E., Lui, K., Wodak, A.D., Feller, J.M., Campbell, T., et al.

(2010). The temporal influence of a heroin shortage on pregnant drug users and their

newborn infants in Sydney, Australia. Australian and New Zealand Journal of

Obstetrics and Gynaecology, 50(3), 230–236.

Prosser, J., Cohen, L.J., Steinfeld, M., Eisenberg, D., London, E.D., & Galynker, I.I. (2006).

Neuropsychological functioning in opiate-dependent subjects receiving and following

methadone maintenance treatment. Drug and Alcohol Dependence, 84, 240–247.

Proudnikov, D., Kroslak, T., Sipe, J.C., Randesi, M., Li, D., Hamon, S., et al. (2010).

Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid

amide hydrolase (FAAH) genes with heroin addiction: Impact of long repeats of

CNR1. The Pharmacogenomics Journal, 10(3), 232–242.

Radenkova-Saeva, J., Kostadinova, R., Michova, A., & Petrunov, B. (2010). Pulmonary

complications related to heroin overdose and some changes in immune reactivity.

Central European Journal of Medicine, 5(4), 508–512.

Ramasamy, P., Lintzeris, N., Sutton, Y., Taylor, H., Day, C.A., & Haber, P.S. (2010). The

outcome of a rapid hepatitis B vaccination programme in a methadone treatment

clinic. Addiction (Abingdon, England), 105(2), 329–334.

Rapeli, P., Kivisaari, R., Autti, T., Kahkonen, S., Puuskari, V., Jokela, O., & Kalska, H.

(2006). Cognitive function during early abstinence from opioid dependence: A

comparison to age, gender, and verbal intelligence matched controls. BMC

Psychiatry, 6, 9.

Ridenour, T.A., Maldonado-Molina, M., Compton, W.M., Spitznagel, E.L., & Cottler, L.B.

(2005). Factors associated with the transition from abuse to dependence among

substance abusers: Implications for a measure of addictive liability. Drug and Alcohol

Dependence, 80, 1–14.

Risser, D., & Schneider, B. (1994). Drug-related deaths between 1985 and 1992 examined at

the Institute of Forensic Medicine in Vienna, Austria. Addiction, 89, 851–857.

Robins, L.N., Helzer, J.E., Hesselbrock, M., & Wish, E. (2010). Vietnam veterans three years

after Vietnam: How our study changed our view of heroin. American Journal on

Addictions, 19(3), 203–211.

Rounsaville, B.J., Jones, C., Novelly, R.A., & Kleber, H. (1982). Neuropsychological

functioning in opiate addicts. Journal of Nervous and Mental Disease, 170, 209–216.



Roy, A. (2010). Risk factors for attempting suicide in heroin addicts. Suicide and Life-

Threatening Behavior, 40(4), 416–420.

Salamina, G., Diecidue, R., Vigna-Taglianti, F., Jarre, P., Schifano, P., Bargagli, A.M., et al.

(2010). Effectiveness of therapies for heroin addiction in retaining patients in

treatment: Results from the VEdeTTE study. Substance Use and Misuse, 45(12),

2076–2092.

Salmon, A.M., van Beek, I., Amin, J., Kaldor, J., & Maher, L. (2010). The impact of a

supervised injecting facility on ambulance call-outs in Sydney, Australia. Addiction

(Abingdon, England), 105(4), 676–683.

Schulte, B., Schutt, S., Brack, J., Isernhagen, K., Deibler, P., Dilg, C., et al. (2010).

Successful treatment of chronic hepatitis C virus infection in severely opioid-

dependent patients under heroin maintenance. Drug and Alcohol Dependence, 109(1–

3), 248–251.

Seecof, R., & Tennant, F.S. (1986). Subjective perceptions of to the intravenous “rush” of

heroin an cocaine in opiate addicts. American Journal of Drug and Alcohol Abuse,

12, 79–87.

Severtson, S.G., Hedden, S.L., Martins, S.S., & Latimer, W.W. (2012). Patterns of cognitive

impairments among heroin and cocaine users: The association with self-reported

learning disabilities and infectious disease. Journal of Learning Disabilities, 45(2),

139–150.

Severtson, S.G., von Thomsen, S., Hedden, S.L., & Latimer, W. (2010). The association

between executive functioning and motivation to enter treatment among regular users

of heroin and/or cocaine in Baltimore, MD. Addictive Behaviors, 35(7), 717–720.

Sticht, M., Mitsubata, J., Tucci, M., & Leri, F. (2010). Reacquisition of heroin and cocaine

place preference involves a memory consolidation process sensitive to systemic and

intra-ventral tegmental area naloxone. Neurobiology of Learning and Memory, 93(2),

248–260.

Strang, J., Metrebian, N., Lintzeris, N., Potts, L., Carnwath, T., Mayet, S., et al. (2010).

Supervised injectable heroin or injectable methadone versus optimised oral

methadone as treatment for chronic heroin addicts in England after persistent failure

in orthodox treatment (RIOTT): A randomised trial. The Lancet, 375(9729), 1885–

1895.

Strasser, J., Wiesbeck, G.A., Meier, N., Stohler, R., & Dursteler-Macfarland, K.M. (2010).

Effects of a single 50% extra dose of methadone on heroin craving and mood in

lower- versus higher-dose methadone patients. Journal of Clinical

Psychopharmacology, 30(4), 450–454.



Szczytkowski, J.L., & Lysle, D.T. (2010). Dopamine D(1) receptors within the basolateral

amygdala mediate heroin-induced conditioned immunomodulation. Journal of

Neuroimmunology, 226(1–2), 38–47.

Tang, A.M., Forrester, J.E., Spiegelman, D., Flanigan, T., Dobs, A., Skinner, S., et al. (2010).

Heavy injection drug use is associated with lower percent body fat in a multi-ethnic

cohort of HIV-positive and HIV-negative drug users from three US cities. American

Journal of Drug and Alcohol Abuse, 36(1), 78–86.

Tull, M.T., Gratz, K.L., Aklin, W.M., & Lejuez, C.W. (2010). A preliminary examination of

the relationships between posttraumatic stress symptoms and crack/cocaine, heroin,

and alcohol dependence. Journal of Anxiety Disorders, 24(1), 55–62.

Uchtenhagen, A. (2010). Heroin-assisted treatment in Switzerland: A case study in policy

change. Addiction, 105(1), 29–37.

Van den Oever, M.C., Lubbers, B.R., Goriounova, N.A., Li, K.W., Van der Schors, R.C.,

Loos, M., et al. (2010). Extracellular matrix plasticity and GABAergic inhibition of

prefrontal cortex pyramidal cells facilitates relapse to heroin seeking.

Neuropsychopharmacology, 35(10), 2120–2133.

Verdejo-García, A., Perales, J., & Pérez-García, M. (2007). Cognitive impulsivity in cocaine

and heroin polysubstance abusers. Addictive Behaviors, 32, 950–966.

Verdejo, A., Toribio, I., Orozco, C., Puente, K.L., & Pérez-García, M. (2005).

Neuropsychological functioning in methadone maintenance patients versus abstinent

heroin abusers. Drug and Alcohol Dependence, 78, 283–288.

Villella, C., Iorio, R., Conte, G., Batocchi, A.P., & Bria, P. (2010). Toxic

leukoencephalopathy after intravenous heroin injection: A case with clinical and

radiological reversibility. Journal of Neurology, 257(11), 1924–1926.

Walter, M., Wiesbeck, G.A., Degen, B., Albrich, J., Oppel, M., Schulz, A., et al. (2010).

Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent

patients. Addiction Biology, 16(1), 145–151.

Walter, M., Wiesbeck, G.A., Riecher-Rossler, A., & Borgwardt, S.J. (2010). Neural effects

of heroin: Relation to anxiety stress. Progress in Neuro-Psychopharmacology and

Biological Psychiatry, 34(5), 816–817.

Wang, H., Zhou, J., Huang, L., Li, X., Fennie, K.P., & Williams, A.B. (2010). Effects of

nurse-delivered home visits combined with telephone calls on medication adherence

and quality of life in HIV-infected heroin users in Hunan of China. Journal of

Clinical Nursing, 19(3–4), 380–388.



Wang, R.F., Tafani, J.A., Frances, B., Bergon, M., Coulais, Y., Zajac, J.M., & Guiraud, R.

(1997). Evaluation of [125I]7α-O-iodoallyl diprenorphine as a new potential SPECT

opioid receptor imaging agent. Nuclear Medicine and Biology, 24, 553–558.

Wang, Z.X., Zhang, J.X., Wu, Q.L., Liu, N., Hu, X.P., Chan, R.C., et al. (2010). Alterations

in the processing of non-drug-related affective stimuli in abstinent heroin addicts.

NeuroImage, 49(1), 971–976.

Warner-Smith, M., Darke, S., Lyndskey, M., & Hall, W. (2001). Heroin overdone: Causes

and consequences. Addiction, 96, 1113–1125.

Wei, W., Ya-rong, W., Wei, Q., Kai, Y., Jie, T., Qiang, L., et al. (2010). Changes in

functional connectivity of ventral anterior cingulate cortex in heroin abusers. Chinese

Medical Journal, 123(12), 1582–1588.

White, J., & Irvine, R. (1999). Mechanisms of fatal opioid overdose. Addiction, 95, 961–972

White, J.M. (2004). Pleasure into pain: The consequences of long-term opioid use. Addictive

Behaviors, 29, 1311–1324.

Wilkins, L., Bissell, P., & Meier, P.S. (2010). Risky injecting practices associated with

snowballing: A qualitative study. Drug and Alcohol Review, 29(3), 256–262.

Workshop, C., & Bird, S.M. (2010). Over 1200 drugs-related deaths and 190,000 opiate-

user-years of follow-up: Relative risks by sex and age group. Addiction Research and

Theory, 18(2), 194–207.

Xiao, L., Wu, Z., Luo, W., & Wei, X. (2010). Quality of life of outpatients in methadone

maintenance treatment clinics. Journal of Acquired Immune Deficiency Syndromes,

53(Suppl 1), S116–120.

Ye, L., Wang, X., Metzger, D.S., Riedel, E., Montaner, L.J., & Ho, W. (2010). Upregulation

of SOCS-3 and PIAS-3 impairs IL-12-mediated interferon-gamma response in CD56

T cells in HCV-infected heroin users. PloS One, 5(3), e9602.

Yeh, Y.W., Lu, R.B., Tao, P.L., Shih, M.C., Lin, W.W., & Huang, S.Y. (2010). Neither

single-marker nor haplotype analyses support an association between the dopamine

transporter gene and heroin dependence in Han Chinese. Genes, Brain, and Behavior,

9(6), 638–647.

Ying, Y., Chenglu, F., Jiang, D., Hanhui, C., & Min, Z. (2010). Gender differences of

temperament and character in heroin dependent patients. Chinese Journal of Drug

Dependence, 19(1), 48–51.

Yongvanitjit, K. (2010). Pulmonary tuberculosis among heroin addicts in Bangkok

metropolitan administration narcotic clinics. Vajira Medical Journal, 51(2), 95–101.



Yuan, K., Qin, W., Dong, M., Liu, J., Liu, P., Zhang, Y., et al. (2010). Combining spatial and

temporal information to explore resting-state networks changes in abstinent heroin-

dependent individuals. Neuroscience Letters, 475(1), 20–24.

Yuan, K., Qin, W., Dong, M., Liu, J., Sun, J., Liu, P., et al. (2010). Gray matter deficits and

resting-state abnormalities in abstinent heroin-dependent individuals. Neuroscience

Letters, 482(2), 101–105.

Yuan, K., Qin, W., Liu, J., Guo, Q., Dong, M., Sun, J., et al. (2010). Altered small-world

brain functional networks and duration of heroin use in male abstinent heroin-

dependent individuals. Neuroscience Letters, 477(1), 37–42.

Yuferov, V., Levran, O., Proudnikov, D., Nielsen, D.A., & Kreek, M.J. (2010). Search for

genetic markers and functional variants involved in the development of opiate and

cocaine addiction and treatment. Annals of the New York Academy of Sciences, 1187,

184–207.

Zhou, L., Lu, B.X., & Yin, J. (2010). Association of cytochrome P4502D6 gene

polymorphism with the susceptibility of heroin spongiform leucoencephalopathy.

Journal of Southern Medical University, 30(3), 572–574, 583.

Zhao, L.Y., Shi, J., Zhang, X.L., Epstein, D.H., Zhang, X.Y., Liu, Y., et al. (2010). Stress

enhances retrieval of drug-related memories in abstinent heroin addicts.

Neuropsychopharmacology, 35(3), 720–726.

Zhao, L.Y., Shi, J., Zhang, X.L., & Lu, L. (2010). Psychosocial stress enhances non-drug-

related positive memory retrieval in male abstinent heroin addicts. Neuroscience

Letters, 485(1), 16–20.

Zhao-sheng, D., Kai-lang, Y., Chen, Z., Yang-ying, Q., & Yong, H. (2010). Comparative

analysis on brain computerized tomography of patients with heroin dependence and

rehabilitation treatments. Journal of Clinical Medicine in Practice, 14(1).

Zunkler, B.J., & Wos-Maganga, M. (2010). Comparison of the effects of methadone and

heroin on human ether-a-go-go-related gene channels. Cardiovascular Toxicology,

10(3), 161–165.

Canadian Centre on Substance Abuse

75 Albert Street, Suite 500 | Ottawa, ON K1P 5E7 | Canada

Phone: 613-235-4048 | Fax: 613-235-8101 | [email protected]

mailto:[email protected]

xperiment.ca content references: heroin · xperiment.ca content references: heroin ... h.b., &...

Documents